BioCryst Pharmaceuticals shares are trading higher ahead of the company's expected phase 1 clinical trial data for BCX9930.
BioCryst Pharmaceuticals shares are trading higher ahead of the company's expected phase 1 clinical trial data for BCX9930.
BioCryst制药公司的股价在该公司预期的BCX9930第一阶段临床试验数据公布之前走高。
BioCryst Pharmaceuticals shares are trading higher ahead of the company's expected phase 1 clinical trial data for BCX9930.
BioCryst制药公司的股价在该公司预期的BCX9930第一阶段临床试验数据公布之前走高。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。